We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
ServiceNow
NOW
$109B
| $1.48M | 0.02% |
29,950
-196,600
| -87% | -$8.64M |
|
577
Inovio Pharmaceuticals
INO
$79.4M
| $1.48M | 0.02% |
32,950
+12,108
| +58% | +$610K |
|
|
LCI
578
DELISTED
Lannett Company, Inc.
LCI
| $1.47M | 0.02% |
46,752
+28,875
| +162% | +$928K |
|
579
Artisan Partners
APAM
$2.86B
| $1.45M | 0.02% |
57,528
-910
| -2% | -$22.2K |
|
|
HTB
580
HomeTrust Bancshares
HTB
$833M
| $1.44M | 0.02% |
57,284
+18,370
| +47% | +$491K |
|
581
HCA Healthcare
HCA
$86.4B
| $1.44M | 0.02% |
11,010
-10,530
| -49% | -$1.41M |
|
582
NCR Voyix
VYX
$1.13B
| $1.43M | 0.02% |
+85,363
| New | +$1.41M |
|
583
BJ's Restaurants
BJRI
$1.45B
| $1.43M | 0.02% |
30,210
-9,580
| -24% | -$481K |
|
584
Standex International
SXI
$3.75B
| $1.42M | 0.02% |
19,368
+6,640
| +52% | +$503K |
|
|
BMCH
585
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.42M | 0.02% |
80,077
+69,116
| +631% | +$1.2M |
|
|
NGHC
586
DELISTED
National General Holdings Corp
NGHC
| $1.4M | 0.02% |
+59,067
| New | +$1.45M |
|
|
SYKE
587
DELISTED
SYKES Enterprises Inc
SYKE
| $1.39M | 0.02% |
49,232
+31,234
| +174% | +$881K |
|
588
Comscore
SCOR
$107M
| $1.38M | 0.02% |
3,395
+280
| +9% | +$114K |
|
|
OMN
589
DELISTED
OMNOVA Solutions Inc.
OMN
| $1.37M | 0.02% |
194,997
+78,424
| +67% | +$627K |
|
590
PJT Partners
PJT
$4.36B
| $1.36M | 0.02% |
32,599
-760
| -2% | -$32.6K |
|
|
CHX
591
DELISTED
ChampionX
CHX
| $1.36M | 0.02% |
+33,182
| New | +$1.23M |
|
|
TRST
592
Trustco Bank Corp NY
TRST
$978M
| $1.36M | 0.02% |
35,098
| – | – |
|
593
Modine Manufacturing
MOD
$12.2B
| $1.35M | 0.02% |
97,614
-151,627
| -61% | -$2.13M |
|
594
Murphy Oil
MUR
$5.38B
| $1.35M | 0.02% |
46,170
-7,100
| -13% | -$201K |
|
595
Lamb Weston
LW
$7.3B
| $1.35M | 0.02% |
18,020
+3,500
| +24% | +$248K |
|
596
Seres Therapeutics
MCRB
$47M
| $1.35M | 0.02% |
9,819
+2,815
| +40% | +$343K |
|
597
Kforce
KFRC
$1.04B
| $1.34M | 0.02% |
38,046
| – | – |
|
|
XIFR
598
XPLR Infrastructure LP
XIFR
$1.19B
| $1.34M | 0.02% |
28,650
-100
| -0.3% | -$4.34K |
|
599
Groupon
GRPN
$1.05B
| $1.33M | 0.02% |
18,799
-38,621
| -67% | -$2.72M |
|
|
ITCI
600
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.33M | 0.02% |
109,584
+37,570
| +52% | +$480K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.